Joachimczyk Paul
Known title: CFOCIK: 0001689220
Joachimczyk Paul's purchase track record
Joachimczyk Paul has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/24/2026 | SON | $400K | +21.4% | pending | — |
| 10/29/2025 | SON | $810K | +21.1% | +26.6% | +3.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SON | ▲ Buy | Option Exercise | 8,348 | $0 | 6/30/2026 | View on chart |
| SON | ▼ Sell | Tax Withholding | 2,534 | $143K | 6/30/2026 | View on chart |
| SON | ▲ Buy | Open Market | 8,058 | $400K | 4/24/2026 | View on chart |
| SON | ▲ Buy | Open Market | 20,317 | $803K | 10/29/2025 | View on chart |
| SON | ▲ Buy | Open Market | 75 | $3K | 10/29/2025 | View on chart |
| SON | ▲ Buy | Open Market | 75 | $3K | 10/29/2025 | View on chart |
| SON | ▲ Buy | Open Market | 23 | $908 | 10/29/2025 | View on chart |
| SON | ▲ Buy | Open Market | 10 | $394 | 10/29/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
UBS cuts Sonoco price target to $51, maintains Neutral rating
UBS has lowered its price target for Sonoco Products to $51 while keeping a Neutral rating. This move places the bank's estimate at the bottom of the current analyst range, which spans from $51 to $70. The stock is currently trading near its support level, reflecting the cautious outlook among some analysts.
UBS cuts Sonoco price target to $51, maintains Neutral rating. UBS has lowered its price target for Sonoco Products to $51 while keeping a Neutral rating. This move places the bank's estimate at the bottom of the current analyst range, which spans from $51 to $70. The stock is currently trading near its support level, reflecting the cautious outlook among some analysts.